Related Experiment Video

Updated: Jul 16, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
10:33

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure

Published on: May 27, 2022

Essential gene identification and drug target prioritization in Aspergillus fumigatus

Wenqi Hu1, Susan Sillaots, Sebastien Lemieux

  • 1Merck Frosst Center of Fungal Genetics, Montreal, Quebec, Canada.

Plos Pathogens
|March 14, 2007
PubMed

Insights

A new conditional promoter replacement (CPR) strategy effectively identifies essential genes in Aspergillus fumigatus. This method aids in discovering new antifungal drug targets for invasive aspergillosis treatment.

Area of Science:

  • Mycology
  • Molecular Biology
  • Medical Mycology

Background:

  • Aspergillus fumigatus is a major human fungal pathogen causing invasive aspergillosis, particularly in immunocompromised individuals.
  • Existing antifungal therapies for invasive aspergillosis are limited in efficacy, safety, and modes of action.
  • There is a critical need for novel antifungal drug targets to combat this life-threatening infection.

Purpose of the Study:

  • To develop and validate a novel conditional promoter replacement (CPR) strategy for identifying essential genes in Aspergillus fumigatus.
  • To utilize this strategy to identify and prioritize potential antifungal drug targets.
  • To assess the utility of the CPR strategy for in vivo phenotypic analysis.

Main Methods:

  • Development of a conditional promoter replacement (CPR) strategy using the A. fumigatus NiiA promoter (pNiiA).
  • Application of the pNiiA-CPR strategy to assess the essentiality of 54 A. fumigatus genes with known essential orthologs in other fungi.
  • Generation of conditional mutants, including an ERG11 double mutant, for in vivo studies.

Main Results:

  • The pNiiA-CPR strategy successfully demonstrated gene essentiality for 35 A. fumigatus genes.
  • The ERG11 gene family (ERG11A and ERG11B) was identified as essential in A. fumigatus, although individual genes were not.
  • Conditional mutants, including the ERG11 double mutant, were unable to establish infection in a mouse model, validating the in vivo applicability of the CPR strategy.

Conclusions:

  • The pNiiA-CPR strategy provides a rapid and reliable method for identifying essential genes in A. fumigatus.
  • This approach facilitates phenotypic characterization and the development of target-based screening assays for new antifungal drugs.
  • The strategy holds promise for accelerating the discovery of novel antifungal agents against Aspergillus fumigatus infections.

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...